InnovAge (NASDAQ: INNV) reported Q4 EPS of ($0.09), $0.05 worse than the analyst estimate of ($0.04). Revenue for the quarter came in at $176.87 million versus the consensus estimate of $175.71 million.

For earnings history and earnings-related data on InnovAge (INNV) click here.